New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors

新型合成致死性药物在体外重新使铂耐药癌细胞对顺铂敏感：PARP 和 ATM 抑制剂联合使用的理由